X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs SANOFI INDIA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD SANOFI INDIA MERCK LTD/
SANOFI INDIA
 
P/E (TTM) x 46.6 34.0 137.2% View Chart
P/BV x 6.1 6.8 89.8% View Chart
Dividend Yield % 0.5 1.3 34.9%  

Financials

 MERCK LTD   SANOFI INDIA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
SANOFI INDIA
Dec-16
MERCK LTD/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1,0604,560 23.2%   
Low Rs6234,400 14.2%   
Sales per share (Unadj.) Rs632.41,028.5 61.5%  
Earnings per share (Unadj.) Rs45.7129.0 35.4%  
Cash flow per share (Unadj.) Rs62.3186.0 33.5%  
Dividends per share (Unadj.) Rs11.0068.00 16.2%  
Dividend yield (eoy) %1.31.5 86.1%  
Book value per share (Unadj.) Rs388.8753.6 51.6%  
Shares outstanding (eoy) m16.6023.03 72.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.34.4 30.5%   
Avg P/E ratio x18.434.7 53.0%  
P/CF ratio (eoy) x13.524.1 56.1%  
Price / Book Value ratio x2.25.9 36.4%  
Dividend payout %24.152.7 45.6%   
Avg Mkt Cap Rs m13,969103,174 13.5%   
No. of employees `0001.63.6 43.7%   
Total wages/salary Rs m1,4873,592 41.4%   
Avg. sales/employee Rs Th6,631.96,537.7 101.4%   
Avg. wages/employee Rs Th939.2991.4 94.7%   
Avg. net profit/employee Rs Th479.4819.8 58.5%   
INCOME DATA
Net Sales Rs m10,49823,686 44.3%  
Other income Rs m242708 34.2%   
Total revenues Rs m10,74124,394 44.0%   
Gross profit Rs m1,1355,281 21.5%  
Depreciation Rs m2761,313 21.0%   
Interest Rs m015 0.0%   
Profit before tax Rs m1,1024,661 23.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3431,691 20.3%   
Profit after tax Rs m7592,970 25.6%  
Gross profit margin %10.822.3 48.5%  
Effective tax rate %31.136.3 85.9%   
Net profit margin %7.212.5 57.7%  
BALANCE SHEET DATA
Current assets Rs m6,41015,673 40.9%   
Current liabilities Rs m8,8286,678 132.2%   
Net working cap to sales %-23.038.0 -60.7%  
Current ratio x0.72.3 30.9%  
Inventory Days Days5876 75.9%  
Debtors Days Days3822 172.0%  
Net fixed assets Rs m1,4068,098 17.4%   
Share capital Rs m166230 72.1%   
"Free" reserves Rs m6,28617,088 36.8%   
Net worth Rs m6,45517,356 37.2%   
Long term debt Rs m00-   
Total assets Rs m8,82825,400 34.8%  
Interest coverage xNM311.7-  
Debt to equity ratio x00-  
Sales to assets ratio x1.20.9 127.5%   
Return on assets %8.611.8 73.1%  
Return on equity %11.817.1 68.7%  
Return on capital %17.126.9 63.4%  
Exports to sales %8.324.5 33.8%   
Imports to sales %21.028.0 75.2%   
Exports (fob) Rs m8695,801 15.0%   
Imports (cif) Rs m2,2096,627 33.3%   
Fx inflow Rs m9597,145 13.4%   
Fx outflow Rs m2,6126,846 38.2%   
Net fx Rs m-1,653299 -552.9%   
CASH FLOW
From Operations Rs m1,0703,226 33.2%  
From Investments Rs m-750-1,555 48.2%  
From Financial Activity Rs m-150-1,818 8.2%  
Net Cashflow Rs m171-147 -116.3%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 60.4 85.8%  
Indian inst/Mut Fund % 18.2 14.4 126.4%  
FIIs % 1.0 14.6 6.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 10.5 277.1%  
Shareholders   28,591 15,184 188.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   SUN PHARMA  WYETH LTD  TORRENT PHARMA  UNICHEM LAB  DR. REDDYS LAB  

Compare MERCK LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Cuts Losses; TCS Up 3%(Closing)

After opening the day in red, share markets in India witnessed volatile trading activity throughout the day but clawed back some gains in the final hours of the trading window.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jun 15, 2018 (Close)

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS